Home › Prostate Cancer › Alabama
Prostate Cancer clinical trials in Alabama
12 studies for Prostate Cancer are looking for participants at sites in Alabama.
Cities in Alabama
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- University of Alabama at Birmingham Cancer Center, Birmingham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06632977DESTINY-PANTUMOUR04
- Research Site, Birmingham
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Clearview Cancer Institute (Crestwood), Huntsville
- Clearview Cancer Institute, Huntsville
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07028853Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- Urology Centers Of Alabama Pc, Homewood
RecruitingPhase 3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06855277Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- University of Alabama at Birmingham, Birmingham
Recruiting
Ages 18 and older · Men · Updated Sep 14, 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- University of Alabama Birmingham Hospital, Birmingham
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- University of Alabama at Birmingham Cancer Center, Birmingham
- The Kirklin Clinic at Acton Road, Birmingham
- Lewis and Faye Manderson Cancer Center, Tuscaloosa
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- Clearview Cancer Institute, Huntsville
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 3, 2026 · NCT07005154AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Dothan
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 26, 2026 · NCT07611110Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- University of Alabama at Birmingham Hospital, Birmingham
RecruitingPhase 1
Ages 18 to 100 · Men · Updated Aug 13, 2026 · NCT05519449International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- University of Alabama- Tuscaloosa, Tuscaloosa
RecruitingObservational study
Ages 21 and older · Men · Updated May 22, 2026 · NCT03151629SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.